Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for Smell Improvement in CRSwNP
NCT05964465Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2023
- Primary completion
- Jan 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Medical University of South Carolina. Started Aug 2023; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05964465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05964465.